Albireo Pharma Inc (NASDAQ:ALBO)

33.13
Delayed Data
As of May 23
 +0.18 / +0.55%
Today’s Change
15.31
Today|||52-Week Range
39.87
+29.41%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close32.95
Today’s open32.80
Day’s range32.21 - 33.23
Volume70,352
Average volume (3 months)72,252
Market cap$368.4M
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+76.35%
Earnings growth (this year)+4.52%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-99.99%
P/E ratioNM
Price/Sales200,174.00
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.04+0.88%
SBBPStrongbridge Biophar...-0.05-0.66%
NEOSNeos Therapeutics In...+0.05+0.70%
CMRXChimerix Inc-0.04-0.85%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 20, 2018
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$1.0K
Annual profit (last year)-$24.4M
Net profit margin-2,441,400.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Ronald H. W. Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts